Skip to content

Stryker SYK Financing Cash Flow

Financing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$530M-94.9%
Axogen logo
AxogenAXGN
$59.51M+2,398%
CONMED logo
CONMEDCNMD
-$22.55M+20.6%
Merit Medical Systems logo
Merit Medical SystemsMMSI
-$6.29M-190%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$63.97M+9,926%

Other financials

Income statement

See full
Revenue$6.0B+2.6%
Gross profit$3.8B+1.8%
Operating income$936.0M+11.8%
Net income$745.0M+13.9%
EPS (diluted)$1.93+14.2%

Balance sheet

See full
Cash & equivalents$2.9B+24.1%
Total debt$14.4B-15.1%
Total assets$46.3B+0.6%

Cash flow

See full
Operating cash flow$581.0M+132%
CapEx$166.0M+35.0%
Free cash flow$415.0M+227%

Valuation

See full
Market cap$127.55B-13.6%
Enterprise value$139.05B-14.2%
P/E38.2×-12.4×
P/S5.1×-1.2×

Profitability

See full
Gross margin63.8%-0.1pp
Operating margin19.7%+4.4pp
Net margin13.2%+0.9pp
FCF margin18.1%+2.7pp

Returns & leverage

See full
Return on equity32.8%
Debt / equity0.8×
Current ratio2.1×+0.5×

Where this comes from

Reported directly by Stryker in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Stryker’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stryker's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stryker's financing cash flow?
Stryker (SYK) reported financing cash flow of -$1.51B in Q1 2026.
How has Stryker's financing cash flow changed year-over-year?
Stryker's financing cash flow decreased by 159.6% year-over-year, from $2.53B to -$1.51B.
What is the long-term trend for Stryker's financing cash flow?
Over 3 years (2021 to 2024), Stryker's financing cash flow has grown at a -39.5% compound annual growth rate (CAGR), from -$2.37B to -$525M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.